X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ONCOLOGIST

期刊標題檢索 ONCOLOGIST 最新評論: Hello, I would like to ask whether withdrawing a submission is done by... (2024-03-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ONCOLOGIST]您好,您是該頁面的第 59871 位訪客。

期刊簡介
期刊名稱ONCOLOGIST ONCOLOGIST
LetPub Score
7.5
52 ratings
Rate

Reputation
8.6

Influence
6.7

Speed
6.8

期刊簡稱ONCOLOGIST
ISSN1083-7159
E-ISSN1549-490X
h-index145
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.401.9911.487
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q155 / 404
Category: Medicine
Subcategory: Cancer Research
Q147 / 230

自引率 (2023-2024)4.20%自引率趨勢
掲載範囲
The Oncologist® is dedicated to translating the latest research developments into the best multidimensional care for cancer patients. Thus, The Oncologist is committed to helping physicians excel in this ever-expanding environment through the publication of timely reviews, original studies, and commentaries on important developments. We believe that the practice of oncology requires both an understanding of a range of disciplines encompassing basic science related to cancer, translational research, and clinical practice, but also the socioeconomic and psychosocial factors that determine access to care and quality of life and function following cancer treatment.
官方網站http://theoncologist.alphamedpress.org/
在線稿件提交https://www.editorialmanager.com/TO
開放訪問No
出版商AlphaMed Press
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年1996
每年文章數317每年文章數趨勢
黃金OA百分比79.47%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ONCOLOGYSCIEQ170/322
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1083-7159%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Ordinary, 3-8 Week(s)
競爭力 *來自作者的數據: Difficult
參考鏈接
相關期刊 【ONCOLOGIST】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    ANNALS OF ONCOLOGYH-index: 210

    CiteScore: 63.90
    CANCER CELLH-index: 295

    CiteScore: 55.20
    JOURNAL OF CLINICAL ONCOLOGYH-index: 494

    CiteScore: 41.20
    LANCET ONCOLOGYH-index: 274

    CiteScore: 62.10
    CANCER RESEARCHH-index: 411

    CiteScore: 16.10
    SEMINARS IN CANCER BIOLOGYH-index: 134

    CiteScore: 26.80
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHH-index: 67

    CiteScore: 18.20
    學科內最受檢索的期刊 頁面查看次數
    CANCER LETTERS326092
    CANCER RESEARCH310905
    BMC CANCER242777
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH197870
    INTERNATIONAL JOURNAL OF CANCER188165
    Asian Pacific Journal of Cancer Prevention184122
    CLINICAL CANCER RESEARCH180931
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY171552
    ONCOLOGY REPORTS171142
    CA-A CANCER JOURNAL FOR CLINICIANS163239
  •  

    ONCOLOGIST ONCOLOGIST
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)
  [ONCOLOGIST] 的評論撰寫評論
作者: 无极妮子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-17 09:01:09 評論於
Hello, I would like to ask whether withdrawing a submission is done by sending a withdrawal email through the online submission system or directly to the editorial office through email
(0) 讚! | 无极妮子

作者: 极乐湛恩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-25 18:33:38 評論於
Please translate the following passage into English and Japanese, and use ":" and "
(0) 讚! | 极乐湛恩

作者: 混元新曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-11-04 19:19:07 評論於
I have Endnotes format and can check the plagiarism for free, please contact me if needed
(0) 讚! | 混元新曦

作者: 流影经艺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 15:47:10 評論於
Did you get any results later? I also sent an email but didn't receive a reply
(0) 讚! | 流影经艺

作者: 是盼芙吖


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-09-15 09:46:59 評論於
How did you solve it later?
(0) 讚! | 是盼芙吖

作者: 洛妃子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-13 22:39:29 評論於
How do we solve this problem?
(0) 讚! | 洛妃子

作者: 洛妃子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-13 19:26:26 評論於
I am also in this situation, always with editors, sending emails to editors without response. How to solve this? Please reply
(0) 讚! | 洛妃子

作者: 洛妃子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-13 10:34:57 評論於
How are things going now?
(0) 讚! | 洛妃子

作者: 平原依凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-01 19:36:13 評論於
Has it changed to Zone 1?
(0) 讚! | 平原依凝

作者: 猫巷少女端丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-17 08:57:55 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0  
Research focus: General Surgery  
Experience sharing: The review process took over a month, including revisions. We did not fully implement the reviewer's suggestions, but we explained our reasons, which the reviewer seemed to understand and agree with. During the second round of revisions, only minor issues were raised by the editor, and the article was accepted within a week. Overall, the process felt thorough and relatively friendly
(0) 讚! | 猫巷少女端丽

作者: 宗室访波


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-27 16:37:27 評論於
Awesome?
(0) 讚! | 宗室访波

作者: 慧青大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-19 20:31:32 評論於
Thank you, the one with 13 points has been accepted~~
(0) 讚! | 慧青大叔

作者: 慧青大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-19 10:51:51 評論於
There will be a separate link for that
(0) 讚! | 慧青大叔

作者: 平原依凝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-18 16:58:08 評論於
Why there is no payment button shown when I proof
(0) 讚! | 平原依凝

作者: 慧青大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-16 20:09:36 評論於
The proof cost 2770 pounds, it's really expensive
(0) 讚! | 慧青大叔

作者: Griselda Webb


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-09 16:37:16 評論於
How long does it usually take to pay the layout fee after the magazine accepts it? And how soon will the magazine be published?
(0) 讚! | Griselda Webb

作者: Griselda Webb


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-09 10:41:44 評論於
Review speed: 6.0 | Submission acceptance rate: 50.0 Focused research direction: Colorectal cancer sharing experience: Can I ask how long it takes to pay the page fee after this journal is accepted, and approximately when it will be published?
(0) 讚! | Griselda Webb

作者: 鲍里斯多恩


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-08 23:57:11 評論於
Wish you good luck!
(0) 讚! | 鲍里斯多恩

作者: 镇逵殿下


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-05-03 20:38:30 評論於
Have you received and reviewed the publication?
(0) 讚! | 镇逵殿下

作者: Alberta Humphrey


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-28 18:03:50 評論於
Review Speed: 6.0 | Submission Hit Rate: 5.0
Emphasized Research Area: Thyroid; Endocrine
Experience Sharing: Brothers, don't submit, minor revision was rejected 2.1 Submitted 2.7 under review 2.20 With Editors 3.1 minor revision 3.17 revised manuscript submitted Resubmission for revision 3.22 Under Review 3.31 With Editors 4.20 With Editor 4.21 Reject
(0) 讚! | Alberta Humphrey

作者: Alberta Humphrey


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-28 17:59:03 評論於
Be cautious when submitting your paper, as the editor is just looking for reasons to reject it. They may choose an unprofessional reviewer who will criticize your work from a biased standpoint. The first reviewer may have minor revisions for you to make. The second reviewer might find fault with the changes you made based on the first reviewer's comments. The revisions were completed within nine days, but the decision was delayed for an additional 20 days before ultimately rejecting the paper. In conclusion, be cautious when submitting, as it could be a waste of time and energy due to unprofessional reviewers and slow editing processes
(0) 讚! | Alberta Humphrey

作者: 慧青大叔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-27 18:11:16 評論於
Review speed: 3.0 | Submission acceptance rate: 50.0 Focus on research direction: tumor Experience sharing: oncologist In fact, it's not easy to submit. I have had two submission experiences, one was in 2017, and the insights have been shared before, and the other one is this one. In November last year, when I was in quarantine at a hotel, my junior sent me her article to revise, I found the content was not written well, so I made some changes casually. After the leader reviewed it, in order to encourage me to revise carefully, he agreed to let me submit, so I put efforts into revising it. Spent a month, submitted it in early January, chose an oncologist, and wanted to give it a try. The next day, it was under review. After two months of review, the leader couldn't wait and kept asking, so I sent an email to inquire. The day after sending the email, it was minor review, one reviewer raised about 7-8 questions, some were easy to answer, and some were not so easy, I answered them carefully, and was given three weeks. In the first two weeks, my junior revised it, and I didn’t intervene, in the last week, I revised it myself. The deadline for resubmission was on Wednesday, and I resubmitted it on Tuesday, and it was accepted on Thursday. This submission went very smoothly, the review process was quick, and the revisions were minor and it only took two days for acceptance, and there were no language issues. I even doubted if this article should have been submitted to a higher-level journal. However, the results were good, two weeks later, another article with a rating of 3.7 was also accepted. It looked good, but these articles are not enough for me to graduate, I must be the first author and in Q2, which is a bit difficult to achieve. Fortunately, while the 3.7-rated article was accepted, another article with a rating of 13 was also under revision, it didn't specify if it was major or minor revisions, it only said "we are interested in your paper but not in its current state". I hope for good luck, and wish for good luck!
(0) 讚! | 慧青大叔

作者: ljxccc


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-04-18 17:32:20 評論於
It has been five months, and there is no news at all.
(0) 讚! | ljxccc

作者: 虎鹤会潮


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-31 20:44:31 評論於
So scary
(0) 讚! | 虎鹤会潮

作者: 无忧0913


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-21 18:41:02 評論於
It's really, really, really slow. I don't know what the editor is doing. They don't reply to emails either. The manuscript was submitted on October 14, 2022, and has been in the hands of the editor all this time without being sent for review. Later, we sent three reminder emails, and it was sent for review in December. Then, on January 1 and 23, 2023, the review comments should have been received, but it has been two months now and the manuscript is still with the editor. We have also sent several emails but have not received any replies.
(1) 讚! | 无忧0913

首頁    上一頁    1    2    3    4    5    下一頁    末頁  (頁
/5)

開始撰寫 [ONCOLOGIST] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*